Hemocorp
Singapore, SG · 1 known investors
Hemo Group develops interventional medical devices for treating neuro-vascular diseases, including ischemic stroke, hemorrhagic stroke, and neuro access, with products such as the Afentta intracranial thrombectomy device. The company markets its devices across Europe, Asia, and the Middle East, with R&D conducted in the US.
Investors · 1
Frequently asked questions
- What does Hemocorp do?
- Hemo Group develops interventional medical devices for treating neuro-vascular diseases, including ischemic stroke, hemorrhagic stroke, and neuro access, with products such as the Afentta intracranial thrombectomy device. The company markets its devices across Europe, Asia, and the Middle East, with R&D conducted in the US.
- Who are Hemocorp's investors?
- Hemocorp's investors include Delos Capital.
- Where is Hemocorp headquartered?
- Hemocorp is headquartered in Singapore, SG.